Meeting Coverage

ECTRIMS

European Committee for Treatment and Research in Multiple Sclerosis

Pragmatic Trials May Help Increase Minority Participation in MS Research

DELIVER-MS shows racial and ethnic diversity in clinical trials can be improved

ECTRIMS over a photo of RAI Exhibition Centre in Amsterdam, Netherlands.

Latest ECTRIMS Meetings

Higher Relapse Rate With Rituximab vs Ocrelizumab in MS Registry Data

Rituximab did not show non-inferiority in comparative effectiveness study

November 1, 2022
Can First MS Symptoms Be Delayed?

ARISE trial investigates radiologically isolated syndrome

October 31, 2022
New Evidence Sheds Light on Stem Cell Transplantation for Progressive MS

Disability, relapses no better than disease-modifying drug

October 30, 2022
No Excess Pregnancy, Infant Risks With Ocrelizumab for MS

Major congenital anomalies, other adverse outcomes were rare

October 28, 2022
Frequent MRI May Spot Active Secondary Progressive MS More Quickly

"If you rely on having a clinical relapse, you may wait a long time"

October 19, 2021
COVID Vaccine Response Varies With MS Treatment Type

How this relates to infection outcomes or risk of infecting others is unknown

October 18, 2021
Quitting Smoking Tied to Slower Motor Decline in Multiple Sclerosis

Analysis suggests smoking cessation has benefits in MS

October 17, 2021
Slowly Expanding Lesions in MS Reduced With BTK Inhibitor

Evobrutinib shows effect on marker of chronic inflammation

October 17, 2021
Virtual Care May Help Multiple Sclerosis Patients Even After the Pandemic

Early study paves the way to look at how telehealth may fit into MS care

October 15, 2021
Novel Anti-CD20 Drug Shows Promise in Relapsing MS

Ublituximab bests teriflunomide in head-to-head phase III trials

October 14, 2021
Some MS Drugs Linked With Worse COVID-19 Outcomes

Registry data looks at risks of hospitalization, ICU admission, ventilation

September 28, 2020
Masitinib Shows Positive Signs in Progressive MS

Tyrosine kinase inhibitor targets innate immune system

September 14, 2020
Depression, Suicidal Thoughts Prevalent in MS

Burden equally high in relapsing-remitting and progressive multiple sclerosis

September 13, 2020
Anti-Inflammatory Drug May Offer Benefit in Progressive MS

Ibudilast seems to diminish brain volume loss

October 29, 2017